Lymphastat Liquid
Product Images NDC 44911-0713

1 FDA label image from Energique, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lymphastat (NDC 44911-0713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lymphastat C (Enrg0578 Lymphastat C 8 12 26)

Lymphastat C (Enrg0578 Lymphastat C 8 12 26)
Drug Facts panel for Lymphastat C liquid oral homeopathic remedy by Energique, Inc. Lists active ingredients with potencies and suggested symptom purposes, such as Candida Albicans and brain fog, Thuja Occidentalis and runny nose. Includes uses for bloating, flatulence, rhinitis; warnings; directions for dosage; storage instructions; inactive ingredients (demineralized water, 20% ethanol); and contact information for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.